CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 8,750,000 shares, an increase of 143.1% from the April 30th total of 3,600,000 shares. Based on an average daily volume of 6,480,000 shares, the short-interest ratio […]

Related Keywords

Seana Mccarthy , Piper Sandler , Susquehanna Fundamental Investments , Sg Americas Securities , Alphamark Advisors , Jefferies Financial Group , Nasdaq , Cytomx Therapeutics Inc , Congress Park Capital , Acadian Asset Management , Cytomx Therapeutics , Get Free Report , Financial Group , Mark Advisors , Asset Management , Fundamental Investments , Spark Capital , Cytomx Therapeutics Daily ,